Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

axatilimab × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 4 Other hematologic neoplasm 3 Tumor-Agnostic 2 Myeloid 2 Lymphoid 1 Gastrointestinal 1

Conditions

Hodgkin Disease 1

Interventions

Rituximab 1395 Cyclophosphamide 1301 Vincristine 667 Doxorubicin 585 Etoposide 528 Prednisone 510 Cytarabine 485 fludarabine 464 Methotrexate 445 Dexamethasone 411 fludarabine phosphate 399 Lenalidomide 354 Filgrastim 343 Bendamustine Hydrochloride 280 Radiotherapy 265 venetoclax 258 ibrutinib 258 obinutuzumab 235 Peripheral Blood Stem Cell Transplantation 234 Melphalan 230 Granulocyte Colony-Stimulating Factor 214 Bortezomib 204 Gemcitabine 200 Whole-Body Irradiation 186 Busulfan 186 Mycophenolic Acid 174 Tacrolimus 164 Specimen Handling 156 Magnetic Resonance Spectroscopy 150 Calcium Dobesilate 150

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05723055 2025-11-26

NAHL

University of Utah

Phase 2 Recruiting

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡